Roivant Sciences (ROIV) Income from Continuing Operations (2020 - 2025)

Historic Income from Continuing Operations for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to -$313.7 million.

  • Roivant Sciences' Income from Continuing Operations fell 5013.57% to -$313.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$962.6 million, marking a year-over-year decrease of 12068.41%. This contributed to the annual value of -$729.8 million for FY2025, which is 11605.16% down from last year.
  • Per Roivant Sciences' latest filing, its Income from Continuing Operations stood at -$313.7 million for Q4 2025, which was down 5013.57% from -$166.0 million recorded in Q3 2025.
  • Roivant Sciences' Income from Continuing Operations' 5-year high stood at $5.1 billion during Q4 2023, with a 5-year trough of -$384.9 million in Q4 2022.
  • For the 5-year period, Roivant Sciences' Income from Continuing Operations averaged around $109.3 million, with its median value being -$244.6 million (2023).
  • As far as peak fluctuations go, Roivant Sciences' Income from Continuing Operations crashed by 116711.8% in 2021, and later surged by 143313.41% in 2023.
  • Over the past 5 years, Roivant Sciences' Income from Continuing Operations (Quarter) stood at -$306.1 million in 2021, then decreased by 25.75% to -$384.9 million in 2022, then surged by 1433.13% to $5.1 billion in 2023, then tumbled by 104.07% to -$208.9 million in 2024, then plummeted by 50.14% to -$313.7 million in 2025.
  • Its Income from Continuing Operations was -$313.7 million in Q4 2025, compared to -$166.0 million in Q3 2025 and -$273.9 million in Q2 2025.